Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Heart Technology was a pioneering medical device company that developed the Rotablator, a rotational atherectomy system designed to treat severely calcified coronary artery disease. The technology utilizes a high-speed, diamond-coated burr to selectively ablate hard plaque while sparing healthy, elastic arterial tissue. This innovation provided interventional cardiologists with a critical tool for managing complex lesions that were otherwise difficult to treat with standard balloon angioplasty. The company's success in the cardiology market led to its acquisition by Boston Scientific in 1995 for approximately $500 million.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Heart Technology.